IP Verse

Stabilizing Camptothecin Pharmaceutical Compositions

Patent No. EP3362049 (titled "Stabilizing Camptothecin Pharmaceutical Compositions") was filed by Ipsen Biopharm on Oct 15, 2016. The application was issued on Jul 9, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GRAF VON STOSCH PATENTANWALTSGESELLSCHAFTApr 8, 2026LEPTHIEN
TEVA PHARMACEUTICALSApr 7, 2026D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3362049

IPSEN BIOPHARM
Application Number
EP16788877A
Filing Date
Oct 15, 2016
Status
Granted And Under Opposition
Jun 6, 2025
Publication Date
Jul 9, 2025
External Links
Slate, Register , Google Patents